Show simple item record

Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2

dc.contributor.authorCrofford, Leslie J.en_US
dc.contributor.authorMcDonagh, Kevin T.en_US
dc.contributor.authorGuo, Sutangen_US
dc.contributor.authorMehta, Hemalen_US
dc.contributor.authorBian, Huiminen_US
dc.contributor.authorPetruzelli, Lilli M.en_US
dc.contributor.authorRoessler, Blake J.en_US
dc.date.accessioned2006-04-19T14:18:06Z
dc.date.available2006-04-19T14:18:06Z
dc.date.issued2005-03en_US
dc.identifier.citationCrofford, Leslie J.; McDonagh, Kevin T.; Guo, Sutang; Mehta, Hemal; Bian, Huimin; Petruzelli, Lilli M.; Roessler, Blake J. (2005)."Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2." The Journal of Gene Medicine 7(3): 288-296. <http://hdl.handle.net/2027.42/35234>en_US
dc.identifier.issn1099-498Xen_US
dc.identifier.issn1521-2254en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/35234
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15515144&dopt=citationen_US
dc.description.abstractBackground Recombinant adenovirus can be administered in vivo to achieve transduction of a number of cell types including human synoviocytes. Immunogenicity of adenoviruses has limited their utility as vectors for gene delivery; however, specific mechanisms underlying the acute inflammatory response to adenovirus are not well understood. Activation of a number of signal transduction pathways occurs rapidly upon adenovirus binding to cell-surface receptors. We investigated stimulated expression of mitogen-activated protein kinases (MAPKs), cyclooxygenase-2 (COX-2) and prostaglandin E 2 (PGE 2 ) in human primary synovial fibroblasts to adenovirus expressing the E. coli Β-galactosidase gene. Methods Cultured rheumatoid synoviocytes were exposed to transduction-competent Ad/RSVlacZ recombinant adenovirus or transduction-incompetent (psoralen/UV-irradiated) Ad/RSVlacZ. The effects on COX-2 expression, PGE 2 levels and MAPK signaling in synoviocytes were assessed using a combination of reverse-transcription polymerase chain reaction amplification and immunoblotting. Results Adenovirus treatment of synoviocytes increased levels of COX-2 mRNA and protein as well as PGE 2 . Psoralen-treated transcriptionally inactive adenovirus was equivalent to untreated adenovirus for early COX-2 induction suggesting that viral genes were not required. Adenovirus treatment stimulated phosphorylation of ERK-1/-2, p38 MAPK, and JNK. Inhibition of the ERK and p38 MAPK pathways inhibited COX-2 expression and PGE 2 production. Conclusions Taken together, these data demonstrate that a MAPK-dependent increase in COX-2 results in local prostaglandin production. These findings have clinical implications for use of adenovirus as vectors for in vivo gene delivery. Copyright © 2004 John Wiley & Sons, Ltd.en_US
dc.format.extent208310 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Ltd.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherGeneticsen_US
dc.titleAdenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA ; Room 5510E, MSRB I, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0680, USA.en_US
dc.contributor.affiliationumDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAen_US
dc.identifier.pmid15515144en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/35234/1/661_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/jgm.661en_US
dc.identifier.sourceThe Journal of Gene Medicineen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.